Efficacy and Safety of Abatacept Over 12 Months in Patients with Lupus Nephritis: Results From a Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II/III Study

被引：0
|
作者：
Furie, Richard [1 ]
Nicholls, Kathy [2 ]
Cheng, Tien-Tsai [3 ,4 ]
Houssiau, Frederic [5 ]
Burgos-Vargas, Ruben [6 ]
Chen, Shun-Le [7 ,8 ,9 ]
Aranda, Richard [10 ]
Meadows-Shropshire, Stephanie [10 ]
Kinaszczuk, Michael [10 ]
Merrill, Joan T. [11 ]
机构：
[1] N Shore Long Isl Jewish Hlth Syst, Lake Success, NY USA
[2] Royal Melbourne Hosp, Melbourne, Vic, Australia
[3] Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan
[4] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan
[5] Clin Univ St Luc, B-1200 Brussels, Belgium
[6] Hosp Gen Mexico City, Mexico City, DF, Mexico
[7] Inst Hlth Sci, Joint Mol Rheumatol Lab, Shanghai, Peoples R China
[8] Shanghai Ren Ji Hosp, Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China
[9] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China
[10] Bristol Myers Squibb Co, Princeton, NJ USA
[11] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA
来源：
ARTHRITIS AND RHEUMATISM | 2011年 / 63卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2469
引用
收藏
页码：S962 / S963
页数：2
相关论文
共 50 条
  • [1] A Phase III Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Abatacept or Placebo on Standard of Care in Patients with Active Class III or IV Lupus Nephritis
    Dooley, Mary A.
    Appel, Gerald B.
    Furie, Richard
    Wofsy, David
    Takeuchi, Tsutomu
    Malvar, Ana
    Doria, Andrea
    Romero-Diaz, Juanita
    Chan, Tak Mao
    Elegbe, Ayanbola
    Jayne, David
    Maldonado, Michael A.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [2] Efficacy and safety of tacrolimus for lupus nephritis: a placebo-controlled double-blind multicenter study
    Miyasaka, Nobuyuki
    Kawai, Shinichi
    Hashimoto, Hiroshi
    [J]. MODERN RHEUMATOLOGY, 2009, 19 (06) : 606 - 615
  • [3] Abatacept for Lupus Nephritis: Alternative Outcome Measures Support Opposing Interpretations of Data From a Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II/III Study
    Wofsy, David
    Shropshire, Stephanie Meadows
    Hillson, Jan L.
    Diamond, Betty
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S964 - S965
  • [4] Efficacy and safety of anamorelin HCl in NSCLC patients: Results from a randomized, double-blind, placebo-controlled, multicenter phase II study
    Temel, J.
    Bondarde, S.
    Jain, M.
    Allen, S.
    Mann, W.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S269 - S270
  • [5] Efficacy and safety of oxycodone DETERx: results of a randomized, double-blind, placebo-controlled phase III study
    Kopecky, E.
    O'Connor, M.
    Varanasi, R.
    Saim, S.
    Fleming, A.
    [J]. JOURNAL OF PAIN, 2015, 16 (04): : S87 - S87
  • [6] EFFICACY AND SAFETY OF BARICITINIB IN PATIENTS WITH ACTIVE LUPUS NEPHRITIS: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 TRIAL
    Hassanien, M.
    Moshrif, A.
    Hetta, H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 34 - 35
  • [7] A Phase II Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Obinutuzumab or Placebo in Combination with Mycophenolate Mofetil in Patients with Active Class III or IV Lupus Nephritis
    Furie, Richard
    Aroca, Gustavo
    Alvarez, Analia
    Fragoso-Loyo, Hilda
    Zuta Santillan, Elizabeth
    Rovin, Brad
    Schindler, Thomas
    Hassan, Imran
    Cascino, Matthew
    Garg, Jay P.
    Malvar, Ana
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [8] A PHASE III, RANDOMIZED, DOUBLE-BLIND, MULTICENTER, PLACEBO-CONTROLLED STUDY OF THE EFFICACY AND SAFETY OF NEUCARDIN™ IN PATIENTS WITH CHRONIC HEART FAILURE
    Gao, Runlin
    Zhang, Jian
    Liu, Heping
    Wang, Lina
    Pang, Xiaohua
    Fu, Lu
    Meng, Fanbo
    Zhou, Mingdong
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 668 - 668
  • [9] A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Treatment With Sirukumab (CNTO 136) in Patients With Active Lupus Nephritis
    Rovin, Brad H.
    van Vollenhoven, Ronald F.
    Aranow, Cynthia
    Wagner, Carrie
    Gordon, Robert
    Zhuang, Yanli
    Belkowski, Stanley
    Hsu, Benjamin
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68 (09) : 2174 - 2183
  • [10] A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PROOF-OF-CONCEPT STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SIRUKUMAB IN PATIENTS WITH ACTIVE LUPUS NEPHRITIS
    van Vollenhoven, R.
    Aranow, C.
    Rovin, B.
    Wagner, C.
    Zhou, B.
    Gordon, R.
    Hsu, B.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 78 - 78
12345